Yak (bovine) brucellosis - Symptoms, Causes, Treatment & Prevention

Overview

Yak (bovine) brucellosis is a zoonotic infection caused primarily by the bacterium Brucella abortus, which also infects cattle, bison, water buffalo, and other bovine species. When yaks—large, shaggy-haired bovines native to the Himalayan plateau, Central Asia, and parts of Siberia—become infected, they can transmit the organism to humans through direct contact with infected tissues, milk, or aborted material.

Human brucellosis is a worldwide disease but is most common in regions where livestock vaccination programs are limited. According to the World Health Organization (WHO), an estimated 500,000 new human cases occur each year, with the highest burden in the Mediterranean, Middle East, Central Asia, and parts of Latin America. In high‑altitude pastoral communities that depend on yak herding, the disease is an under‑recognized occupational hazard.

Anyone who works closely with yaks—herders, veterinarians, abattoir workers, and family members who handle milk or meat—can become infected. Infections are not limited to the Himalayas; yak farming is expanding into Mongolia, Pakistan, and even parts of the United States (e.g., experimental farms), so clinicians worldwide should be aware of this form of brucellosis.

Symptoms

Brucellosis is often called “undulant fever” because the fever can rise and fall in a wave‑like pattern. Symptoms usually appear 2 weeks to 2 months after exposure, but the incubation period can be as short as 5 days or as long as several months.

Acute Phase (first 2‑4 weeks)

• Fever – low‑grade (38‑39 °C) but may become intermittent (undulant).
• Night sweats – soaking‑wet sheets are common.
• Fatigue & malaise – profound tiredness that does not improve with rest.
• Musculoskeletal pain – especially in the lower back, hips, and knees.
• Headache – often dull and persistent.
• Arthralgia – joint pain without obvious swelling.
• Loss of appetite & weight loss.
• Chills – often preceding fever spikes.

Sub‑Acute / Chronic Phase (weeks to months)

• Recurrent fever – the classic “undulant” pattern.
• Chronic fatigue that may interfere with daily activities.
• Persistent arthralgia or arthritis – most often affecting the sacroiliac joints, sacrum, or peripheral large joints.
• Osteomyelitis – infection of bone, especially the spine.
• Genitourinary involvement – epididymo‑orchitis in men, pelvic inflammatory disease in women.
• Endocarditis – rare but life‑threatening infection of heart valves.
• Neurologic signs – meningitis, encephalitis, or peripheral neuropathy (rare).
• Hepatosplenomegaly – enlarged liver and spleen may be palpable.
• Skin manifestations – erythema nodosum or maculopapular rash.

Because the signs are non‑specific, brucellosis is often misdiagnosed as malaria, typhoid, or viral infection, particularly in endemic areas.

Causes and Risk Factors

Microbiologic Cause

Human infection is caused by Brucella spp. that are primarily adapted to bovine hosts:

• Brucella abortus – most common in yak‑derived cases.
• Brucella melitensis – occasional cross‑species transmission in mixed herding systems.

Transmission Pathways

• Direct contact with infected placentas, aborted fetuses, uterine discharge, or raw milk.
• Inhalation of aerosolized bacteria during birthing assistance or processing of meat.
• Ingestion of unpasteurized yak milk or dairy products.
• Percutaneous inoculation via skin cuts or abrasions.
• Rarely, person‑to‑person transmission (e.g., sexual, vertical) has been documented but is exceedingly uncommon.

Who Is at Higher Risk?

• Yak herders and shepherds who assist with parturition.
• Veterinary staff and animal‑health workers.
• Abattoir employees handling carcasses or off‑alms.
• Family members consuming raw yak milk or homemade cheese.
• Travelers staying in rural yak‑rearing communities without vaccination or biosafety measures.

Environmental & Socio‑economic Factors

• Lack of systematic vaccination of yak herds (most national programs focus on cattle).
• Poor access to veterinary services and diagnostics.
• Traditional customs that favor raw dairy consumption.
• High‑altitude, nomadic grazing that limits disease‑control surveillance.

Diagnosis

Timely diagnosis requires a combination of clinical suspicion, exposure history, and laboratory testing.

Initial Clinical Evaluation

• Detailed occupational and dietary history (raw milk, animal contact).
• Physical exam focusing on fever pattern, joint tenderness, hepatosplenomegaly, and neurologic signs.

Laboratory Tests

1. Serology
   • Standard Agglutination Test (SAT) – detects anti‑Brucella IgG/IgM; a titer ≥1:160 is generally considered diagnostic in endemic areas.
   • ELISA (Enzyme‑Linked Immunosorbent Assay) – more sensitive for chronic disease; differentiates IgG and IgM.
   • Rose‑Bengal Plate Test – rapid screening; positive results require confirmatory testing.
2. Blood Cultures
   • Culture on specialized media (e.g., Castaneda biphasic medium) yields the organism in 30‑70 % of acute cases.
   • Incubation may take up to 6 weeks; biosafety level‑3 (BSL‑3) precautions are required.
3. Molecular Methods
   • Polymerase Chain Reaction (PCR) targeting the bcsp31 gene provides rapid confirmation, especially when cultures are negative.
   • Real‑time PCR can quantify bacterial load, useful for monitoring therapy.
4. Imaging (if indicated)
   • Joint X‑ray or MRI for chronic arthritis/osteomyelitis.
   • Echocardiography if endocarditis is suspected.

Diagnostic Criteria (CDC/WHO)

Diagnosis is confirmed when any one of the following is present:

• Isolation of Brucella from a clinical specimen.
• Positive serology (SAT ≥1:160 or ELISA IgG/IgM above cut‑off) together with compatible clinical syndrome.
• Positive PCR with appropriate clinical correlation.

Treatment Options

Because Brucella is an intracellular pathogen, combination therapy that penetrates host cells is essential. Treatment regimens are guided by the World Health Organization (WHO) and the Infectious Diseases Society of America (IDSA).

First‑Line Antibiotic Regimens

1. Doxycycline + Rifampin (6‑week course)
   • Doxycycline 100 mg orally twice daily.
   • Rifampin 600‑900 mg once daily.
   • Effective for most uncomplicated acute cases.
2. Doxycycline + Streptomycin** (3‑month course for severe disease)
   • Doxycycline 100 mg orally twice daily.
   • Streptomycin 1 g intramuscularly daily for 2‑3 weeks.
   • Preferred for osteo‑articular involvement, neurobrucellosis, or endocarditis.
3. Doxycycline + Gentamicin** (alternative to streptomycin)
   • Gentamicin 5 mg/kg IV/IM daily for 7‑10 days.

Special Situations

• Pregnant women: Avoid doxycycline and rifampin. Preferred regimen is trimethoprim‑sulfamethoxazole (if not contraindicated) plus a macrolide; however, data are limited, and consultation with an infectious‑disease specialist is advised.
• Children <8 years: Use trimethoprim‑sulfamethoxazole or rifampin‑based regimens; doxycycline is generally avoided.
• Neurobrucellosis or endocarditis: Extend therapy to 12‑18 months and include a third agent (e.g., ceftriaxone) for adequate CSF penetration.

Adjunctive Measures

• Analgesics and anti‑inflammatory drugs for joint pain.
• Physical therapy to maintain joint range of motion.
• Regular monitoring of liver function (rifampin) and renal function (aminoglycosides).

Follow‑Up

Serologic titers should be repeated at 6 weeks, 3 months, and 6 months to ensure decline. Persistent high titers may indicate relapse and require re‑evaluation.

Living with Yak (bovine) Brucellosis

While the disease can be chronic, most patients can return to normal activities with proper treatment and self‑care.

Daily Management Tips

• Medication adherence – set alarms or use pill boxes; never stop antibiotics early, even if you feel better.
• Hydration and nutrition – adequate fluids help fever management; a balanced diet supports immune recovery.
• Joint care – low‑impact exercises (e.g., walking, swimming) and regular stretching reduce stiffness.
• Heat & rest – use warm compresses for painful joints; schedule short, frequent rests if fatigue is severe.
• Monitor symptoms – keep a symptom diary to detect fever spikes or new joint pains early.
• Vaccination of yaks – encourage community vaccination programs; a healthy herd reduces re‑infection risk.
• Safe food practices – consume only pasteurized milk and properly cooked meat.

Psychosocial Support

Chronic fatigue and recurring fevers can cause anxiety and depression. Seek counseling, join local support groups, and involve family in the care plan.

Prevention

Prevention is a shared responsibility between individuals, communities, and public‑health authorities.

For At‑Risk Individuals

• Wear protective gloves, aprons, and eye protection when handling birthing materials or carcasses.
• Wash hands thoroughly with soap and water after animal contact.
• Avoid drinking raw yak milk; boil or pasteurize it for at least 5 minutes.
• Use disinfectants (e.g., 1 % bleach) on surfaces contaminated with animal fluids.
• Promptly report abortions or stillbirths in yaks to veterinary services.

Community‑Level Strategies

• Vaccination of herd – Use the Brucella abortus strain 19 or RB51 vaccine adapted for yak physiology; local veterinary services can tailor schedules.
• Implement surveillance programs that test bulk milk and sentinel animals for seropositivity.
• Educate schools and community centers about the risks of raw dairy consumption.
• Establish animal‑health extension teams to assist herders with safe birthing practices.

Policy Recommendations

• Integrate yak brucellosis control into national One Health frameworks (human, animal, environmental health).
• Allocate resources for BSL‑3 laboratory capacity in endemic regions.
• Support research on yak‑specific vaccine formulations.

Complications

If untreated or inadequately treated, brucellosis can progress to serious, sometimes fatal, conditions.

• Chronic Arthritis – irreversible joint damage, possibly requiring orthopedic surgery.
• Osteomyelitis – infection of bone, often the spine, leading to vertebral collapse.
• Endocarditis – infection of heart valves; carries a mortality rate >30 % without surgery.
• Neurobrucellosis – meningitis, encephalitis, or peripheral neuropathy; may cause permanent neurologic deficits.
• Genitourinary complications – epididymo‑orchitis, prostatitis, or pelvic inflammatory disease, potentially affecting fertility.
• Hepatosplenic involvement – granulomatous hepatitis or splenomegaly, occasionally leading to portal hypertension.
• Relapse – occurs in 5‑15 % of cases, often linked to premature discontinuation of therapy.

When to Seek Emergency Care

Warning signs that require immediate medical attention:

• Sudden, high‑grade fever >39.5 °C persisting >48 hours.
• Severe chest pain or shortness of breath (possible endocarditis or pulmonary involvement).
• Intense abdominal pain with signs of peritonitis.
• New onset of neurologic deficits – weakness, confusion, severe headache, or loss of consciousness.
• Rapidly worsening joint swelling with redness, warmth, or limited movement (suspect septic arthritis).
• Unexplained bleeding, jaundice, or dark urine (possible hepatic involvement).

If any of these occur, go to the nearest emergency department or call emergency services right away.

References

• Mayo Clinic. Brucellosis. https://www.mayoclinic.org
• World Health Organization. Brucellosis Fact Sheet. https://www.who.int
• Centers for Disease Control and Prevention. Brucellosis – Epidemiology & Surveillance. https://www.cdc.gov
• National Institutes of Health, National Center for Complementary & Integrative Health. Brucellosis Treatment Guidelines. https://www.ncbi.nlm.nih.gov
• Cleveland Clinic. Brucellosis: Diagnosis & Management. https://my.clevelandclinic.org
• R. Selim et al., “Brucellosis in Yak Populations of the Himalayas,” Veterinary Microbiology, 2022.
• WHO & FAO. One Health Approach to Zoonoses. 2021.